• 1
    Fuchs VR, Hahn JS: How does Canada do it? A comparison of expenditure for physicians' services in the United States and Canada N Engl J Med 323: 884890, 1990
  • 2
    Redelmeier DA, Fuchs VR: Hospital expenditures in the United States and Canada. N Engl J Med 328: 772778, 1993
  • 3
    Newhouse JP, Anderson G, Roos LL: Hospital spending in the United States and Canada: a comparison. Health Aff 7: 616, 1988
  • 4
    Lubeck DP, Yelin EH: A question of value: measuring the impact of chronic disease. Milbank Q 66: 444464, 1988
  • 5
    Waldo D, Lazenky H: Demographic characteristics and health care use and expenditures by the aged in the US. 1977–1984. Health Care Financing Rev 6: 129, 1984
  • 6
    Felts W, Yelin EH: The economic impact of the rheumatic diseases in the United States. J Rheumatol 16: 867884, 1989
  • 7
    Yelin EH, Katz PP: Labor force participation among persons with musculoskeletal conditions, 1970–1987: national estimates derived from a series of cross-sections. Arthritis Rheum 34: 13611370, 1991
  • 8
    Yelin EH: Work disability and rheumatoid arthritis. In, Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. Edited by FWolfe, TPincus. New York, Marcel Dekker, 1994
  • 9
    Badley EM: The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher. J Rheumatol 22: 204206, 1995
  • 10
    Lubeck D: The economic impact of rheumatoid arthritis. In, Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. Edited by FWolfe, TPincus. New York, Marcel Dekker, 1994
  • 11
    Finn D, Allen P, Hoffstein P, Goldman D, Petri M: Economic costs of systemic lupus erythematosus: a five year prospective study (abstract). Arthritis Rheum 36 (Suppl 9): S192, 1993
  • 12
    Petri M, Genovese M: Incidence of and risk factors for hospitalizations in systemic lupus erythematosus. J Rheumatol 19: 15591565, 1992
  • 13
    McInnes PM, Schuttinga J, Sanslone WR, Stark SP, Klippel JH: The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide. Arthritis Rheum 37: 10001006, 1994
  • 14
    Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF: A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 36: 15481559, 1993
  • 15
    Lacaille D, Clarke AE, Bloch DA, Danoff D, Esdaile JM: The impact of disease activity, treatment, and disease severity on short-term costs of systemic lupus erythematosus. J Rheumatol 21: 1448453, 1994
  • 16
    Clarke AE, Bloch DA, Danoff DS, Esdaile JM: Decreasing costs and improving outcomes in SLE: using regression trees to develop health policy. J Rheumatol 21: 22462253, 1994
  • 17
    Clarke AE, Esdaile JM: Systemic lupus erythematosus: disease activity, severity, treatment, and costs (letter). J Rheumatol 22: 189190, 1995
  • 18
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 19
    Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23: 137145, 1980
  • 20
    Hodgson TA, Meiners MR: Cost-of-illness methodology: a guide to current practices and procedures. Milbank Q 60: 429462, 1982
  • 21
    Scitovsky AA: Estimating the direct costs of illness. Milbank Q 60: 463491, 1982
  • 22
    Luce BR, Elixhauser A: Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 6: 5775, 1990
  • 23
    Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH: A multicenter study of annual health services utilization and costs in rheumatoid arthritis. Arthritis Rheum 29: 488493, 1986
  • 24
    Meenan RF, Gertman PM, Mason JH: Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 23: 146152, 1890
  • 25
    Brown JH, Kazis LE, Spitz PW, Gertman P, Fries JF, Meenan RF: The dimensions of health outcomes: a cross-validated examination of health status measurement. Am J Public Health 74: 159161, 1984
  • 26
    Physician Payment Review Commission: Annual Report to Congress. Washington, DC, 1995
  • 27
    Statistics Directorate: Main Economic Indicators, November 1993. Paris, OECD, 1993
  • 28
    Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford, Oxford University Press, 1987
  • 29
    Statistics Canada: Total Operating Expenses per Patient-Day, Reporting Hospitals. by Type and Size of Hospital: Canada and Provinces, 1987–88. Vol. 1, no. 1. Ottawa, Hospital Statistics Preliminary Annual Report, 1989
  • 30
    Carmichael D: Case weighting methods: a review by the HMRI Database Committee. Ontario, Don Mills, 1988
  • 31
    Detsky AS, O'Rourke K, Naylor CD, Stacey SR, Kitchens JM: Containing Ontario's hospital costs under universal insurance in the 1980's: what was the record? Can Med Assoc J 142: 556572, 1990
  • 32
    Henke, CJ, Epstein WV: Practice variation in rheumatologists' encounters with their patients who have rheumatoid arthritis. Med Care 29: 799812, 1991
  • 33
    Evans RG, Lomas J, Barer ML, Labelle RJ, Fooks C, Stoddart GL, Anderson GM, Feeny D, Gafni A, Torrance GW, Tholl WG: Controlling health expenditures: the Canadian reality. N Engl J Med 320: 571577, 1989
  • 34
    Sandier S: Health service utilization and physician income trends. Health Care Finance Rev 11: 3348, 1989
  • 35
    Ginzberg E: Men, Money, and Medicine. New York, Columbia University Press, 1969
  • 36
    Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE, Sutherland W, Pilote L, Armstrong PW: Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 331: 11301135, 1994
  • 37
    Rouleau JL, Moyé LA, Pfeffer MA, Arnold JMD, Bernstein V, Cuddy TE, Dagenais GR, Geltman EM, Goldman S, Gordon D, Hamm P, Klein M, Lamas GA, McCans J, McEwan P, Menapace FJ, Parker JO, Sestier F, Sussex B, Braunwald E: A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 328: 779784, 1993
  • 38
    Pilote L, Racine N, Hlatky MA: Differences in the treatment of myocardial infarction in the United States and Canada: a comparison of two university hospitals. Arch Intern Med 154: 10901096, 1994
  • 39
    Roos LL, Fisher ES, Sharp SM, Newhouse JP, Anderson G, Bubolz TA: Postsurgical mortality in Manitoba and New England. JAMA 263: 24532458, 1990
  • 40
    Hamilton VH, Hamilton B, Mayo N: What are the costs of queuing for hip fracture surgery in Quebec? Working Paper, Department of Economics, McGill University, 1994
  • 41
    Coyte PC, Wright JG, Hawker GA, Bombardier C, Dittus RS, Paul JE, Freund DA, Ho E: Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med 331: 10681071, 1994
  • 42
    Rublee DA: Medical technology in Canada, Germany, and the United States. Health Aff 8: 178181, 1989
  • 43
    Inglehart JK: Canada's health care system faces its problems. N Engl J Med 322: 562568, 1990
  • 44
    Krasny J, Ferrier IR: A closer look at health care in Canada. Health Aff 10: 152158, 1991
  • 45
    Katz SJ, Mizgala HF, Welch HG: British Columbia sends patients to Seattle for coronary artery surgery: bypassing the queue in Canada. JAMA 266: 11081111, 1991
  • 46
    Higginson LAJ, Cairns JA, Keon WJ, Smith ER: Rates of cardiac catheterization, coronary angioplasty and open-heart surgery in adults in Canada. Can Med Assoc J 146: 921925, 1992
  • 47
    Morin JE, Symes JF, Guerraty AJ, Poirier NL, Sampalis J: Coronary artery bypass profile in Canada and the United States. Can J Cardiol 6: 319322, 1990
  • 48
    Carrier M, Pineault R, Tremblay N, Pelletier C: Outcome of rationing access to open-heart surgery: effect of the wait for elective surgery on patient outcome. Can Med Assoc J 149: 11171122, 1993